- OSU logo - The Ohio State University www.osu.edu
-
-
-

      Selective Investment 2000 Award Recipients

-
Introduction
Cardiovascular Engineering
Department of Economics
Department of English
College of Law
Department of Mathematics
Selective Investment Evaluation Committee
1999 Award Recipients
1998 Award Recipients


























-

Cardiovascular Bioengineering will use its Selective Investment Award to:


• Attain national leadership for a newly formed Department of Biomedical Engineering;

• Establish a world-leading new graduate program in cardiovascular bioengineering;

• Recruit nine outstanding senior faculty members over the next four years, each being a split appointment between Engineering and Medicine & Public Health;

• Enhance our existing interdisciplinary strength (biomechanics, biomaterials, and hemodynamics) and thus "secure academic primacy" therein; and

• Add strength in promising new fields, e.g. nanotechnology, robotic surgery, genetic engineering, and tissue engineering.

 -

 

Cardiovascular Bioengineering

Video Clip

Already the national leader in the use of robotics surgery and renowned for research in microdevices that could be used for drug delivery (nanotechnology), Ohio State expects to become a world leader in biomedical engineering by combining the expertise of engineers and clinicians to find innovative ways to diagnose and treat heart disease.

Mauro Ferrari
Mauro Ferrari, director, Biomedical Engineering Center; associate director, Heart and Lung Research Institute



The Colleges of Medicine and Public Health and Engineering joined in a proposal to strengthen multidisciplinary collaborations by bringing together six units: the Biomedical Engineering Center, Cardiothoracic Surgery, Cardiology, the Heart and Lung Research Institute, Chemical Engineering, and Materials Science and Engineering.

Those spearheading the proposal say this multidisciplinary approach will eliminate academic barriers and create a seamless environment for clinicians and engineers to work together to bring new technologies into the domain of patient care.

Nine hires, all split appointments, are proposed over four years to complement the current faculty and researchers specializing in these combined disciplines. Researchers envision advances in the development of metal alloys and drug-delivery systems that will increase effectiveness of treatment and reduce p atient side effects in the fight against the leading cause of death in the United States.

Robert Michler
Robert Michler, Karl P. Klassen Professor of Surgery; co-director, Heart and Lung Research Institute

"The people we hire are going to be living and breathing more than one discipline," said Robert Michler, chief of cardiothoracic surgery, co-director of the Heart and Lung Research Institute, and the Karl P. Klassen professor of surgery. "As a result of that, the natural kinds of collaborations that you want to occur will occur. We'll see some world-class events happening right here at Ohio State."

Mauro Ferrari, director of the Biomedical Engineering Center and associate director of the Heart and Lung Research Institute, said the Selective Investment proposal was designed to position Ohio State as home to a top U.S. biomedical engineering program. "We expect to attain leadership by focusing on classes of diseases," said Ferrari, also professor of internal medicine, mechanical engineering and materials science. "We are starting with cardiology, and plan to follow up in the areas of oncology and endocrinology."

 

 

 

       
The Ohio State University